Elan Corp. plc To Suspend Trading for Up to Two Days

Elan Corp. plc (ELN) will suspend trading of its securities (ADRs and ordinary shares) on March 7 until the completion of a scheduled U.S. Food and Drug Administration Advisory Committee meeting to review Tysabri. The stock fell $1.25 to $12.70.